LLY

Eli Lilly and Company
Pharmaceuticals

Cash & Equivalents

$7.27B
As of 2025-12-31
Current Price: $939.47 (as of 2026-04-12)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $7.27B
Total Obligations: -$77.46B
$-70.19B
Per share: $-78.22
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $7.27B
AR: $17.76B
Total Obligations: -$77.46B
$-52.43B
Per share: $-58.43
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $7.27B
AR: $17.76B
Inventory: $13.74B
Total Obligations: -$77.46B
$-38.69B
Per share: $-43.11
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-70.19B$-78.22
Liquid Liquidation Value$-52.43B$-58.43
Operating Liquidation Value$-38.69B$-43.11

Key Components (as of 2025-12-31)

Cash & Equivalents$7.27B
Accounts Receivable$17.76B
Inventory$13.74B
Current Liabilities$35.23B
Long-term Debt$40.87B
Op. Lease Liability$1.36B
Finance LeaseN/A
Shares Outstanding897.3M

Explore all 166 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31 $7.27B $17.76B $13.74B $5.38B $35.23B $40.87B $1.36B N/A
2025-09-30 $9.79B $16.11B $12.18B $4.26B $40.14B $40.87B N/A N/A
2025-06-30 $3.38B $14.17B $11.01B $4.08B $39.02B $34.18B N/A N/A
2025-03-31 $3.09B $12.04B $9.31B $3.44B $30.07B $34.50B N/A N/A
2024-12-31 $3.27B $11.01B $7.59B $3.23B $28.38B $28.53B $1.15B N/A
2024-09-30 $3.37B $10.29B $7.46B $2.89B $24.67B $29.05B N/A N/A
2024-06-30 $3.22B $11.03B $6.48B $2.92B $27.12B $23.73B N/A N/A
2024-03-31 $2.46B $7.89B $6.10B $2.47B $18.60B $24.56B N/A N/A

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-12 View
2025-09-30 10-Q 2025-10-30 View
2025-06-30 10-Q 2025-08-07 View
2025-03-31 10-Q 2025-05-01 View
2024-12-31 10-K 2025-02-19 View
2024-09-30 10-Q 2024-10-30 View
2024-06-30 10-Q 2024-08-08 View
2024-03-31 10-Q 2024-04-30 View